Mylan Investor Relations

Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 2,700 generic and branded pharmaceuticals, including antiretroviral therapies on which approximately 50% of people being treated for HIV/AIDS in the developing world depend. We market our products in more than 165 countries and territories. Our global R&D and manufacturing platform includes more than 50 facilities, and we are one of the world's largest producers of active pharmaceutical ingredients. Every member of our more than 40,000-strong workforce is dedicated to creating better health for a better world, one person at a time.

 

Mylan (MYL) NASDAQ | Dec 8, 2016, 4:00 ET

36.06
+ 1.56
Day High: 36.08
Day Low: 34.24
Volume: 9,101,676
52-Week High: 55.51
52-Week Low: 33.60

Leadership

In order to set new standards in healthcare, we have leaders dedicated to helping people gain access to affordable medicine on a global scale. Learn about the passionate people who carry out Mylan’s day-to-day business and bring quality to our facilities.

Mylan will provide shareholders, upon request, a hard copy of its latest 10-K free of charge.